Question follow-through · 112218
Abortion: Gender
To ask the Secretary of State for Health and Social Care, if he will make it his policy to require abortion providers to provide clear guidance regarding the legality of procuring a termination on the basis of sex.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 10 Feb 2026
- Target answer date
- 23 Feb 2026
- Answer
- 2 Mar 2026 · 20 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Health Services: Transgender People · 11 Feb 2026
- Gender Dysphoria: Health Services · 11 Feb 2026
- Gender Dysphoria: Children · 11 Feb 2026
- Puberty Suppressing Hormones: Clinical Trials · 11 Feb 2026
- Surrogacy · 12 Mar 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, if he will make it his policy to require abortion providers to provide clear guidance regarding the legality of procuring a termination on the basis of sex.
23 Feb 2026
Target answer date
Date supplied by the official written-questions record.
2 Mar 2026
Answer published
There is no policy requirement for abortion providers to provide guidance regarding the legality of procuring a termination on the basis of sex, as all abortion providers must comply with the legal requirements set out in the Abortion Act 1967. The Depart...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Health Services: Transgender People
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to support detransitioners.
Gender Dysphoria: Health Services
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to implement a data linkage study of the Gender Identity Development Services.
Gender Dysphoria: Children
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his polices on the care of gender distressed children of the US judgment in the case of Fox Varian.
Puberty Suppressing Hormones: Clinical Trials
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether he has had discussions with whistleblowers from the former Tavistock Gender Identity Development Service regarding the PATHWAYS Puberty Blocker Trial.
Surrogacy
12 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the increase in the number of children entering the UK who have been born through surrogacy in countries where commercial surrogacy oper
Surrogacy
12 Mar 2026 · To ask the Secretary of State for Health and Social Care, what information his Department holds on trends in the number of children born via surrogacy abroad, in particular in (a) Kazakhstan and (b) Nigeria.
Surgical Mesh Implants
12 Mar 2026 · To ask the Secretary of State for Health and Social Care, how many patients have reported adverse outcomes following rectopexy mesh procedures in the last ten years; and whether his Department has considered those cases in determining eligibility for mesh
Coronavirus: Vaccination
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment was made of the potential merits of including an examination of the evidence base relating to the spike protein and lipid nanoparticles used in Covid-19 mRNA vaccines within the sco
Heart Diseases: Yellow Card Scheme
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, what steps the Medicines and Healthcare products Regulatory Agency is taking to improve clinician reporting of myocarditis and pericarditis in the Yellow Card system; and whether the Department has
Medicines and Healthcare products Regulatory Agency: Finance
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether the Department has modelled alternative funding structures for the Medicines and Healthcare products Regulatory Agency that would reduce reliance on industry fees; and if it will publish an
Medicines and Healthcare products Regulatory Agency: Conflict of Interests
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, how many whistleblowing reports relating to conflicts of interest have been submitted within the Medicines and Healthcare products Regulatory Agency in each of the last five years; and whether the
Medicines and Healthcare products Regulatory Agency: Staff
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, how many staff of the Medicines and Healthcare products Regulatory Agency have, in each of the last five years, (a) moved to roles with pharmaceutical companies or industry-funded bodies and (b) jo